222 related articles for article (PubMed ID: 29101827)
1. Differential T cell subsets and cytokine profile between steady-state and G-CSF-primed bone marrow and its association with graft-versus-host disease.
León-Rodríguez E; Rivera-Franco MM; Gómez-Martín D; Romo-Tena J; Juárez-Vega G; Merayo-Chalico J; Alcocer-Varela J
Leuk Res; 2017 Dec; 63():47-52. PubMed ID: 29101827
[TBL] [Abstract][Full Text] [Related]
2. Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.
Zhao XY; Wang YT; Mo XD; Zhao XS; Wang YZ; Chang YJ; Huang XJ
J Transl Med; 2015 May; 13():145. PubMed ID: 25948100
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
4. [Immune tolerance induced by cytokines in allogeneic hematopoietic stem cell transplantation].
Chang YJ; Huang XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 41(2):208-11. PubMed ID: 19377632
[TBL] [Abstract][Full Text] [Related]
5. Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions.
Huang XJ; Chang YJ; Zhao XY
Transpl Immunol; 2007 Apr; 17(3):193-7. PubMed ID: 17331846
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes and graft characteristics in pediatric hematopoietic stem cell transplantation: Effect of granulocyte-colony stimulating factor priming.
Fettah A; Özbek N; Azık F; Tavil B; Özgüner M; Avcı Z; Işık P; Yaralı N; Uçkan D; Tunç B
Transfus Apher Sci; 2015 Jun; 52(3):332-8. PubMed ID: 25779226
[TBL] [Abstract][Full Text] [Related]
7. Reduced BUCY 2 and G-CSF-primed bone marrow associates with low graft-versus-host-disease and transplant-related mortality in allogeneic HSCT.
Leon Rodriguez E; Rivera Franco MM; Perez Alvarez SI
Ann Hematol; 2017 Sep; 96(9):1525-1531. PubMed ID: 28691152
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of CCR5 Expression on T Lymphocytes between the Bone Marrow and Peripheral Blood Grafts after Mobilization].
Wang M; Ren HY; Sun H; Xie XS; Ma J; Gan SL; Liu YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):821-6. PubMed ID: 27342517
[TBL] [Abstract][Full Text] [Related]
9. G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Wen Q; Kong Y; Zhao HY; Zhang YY; Han TT; Wang Y; Xu LP; Zhang XH; Huang XJ
Bone Marrow Transplant; 2019 Sep; 54(9):1419-1433. PubMed ID: 30683906
[TBL] [Abstract][Full Text] [Related]
10. [Comparative analysis of naive and memory CD4(+) and CD8(+) T-cell subsets in rhG-CSF mobilized peripheral blood and steady-state bone marrow].
Huo MR; Zhao XY; Chang YJ; Luo XH; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):605-9. PubMed ID: 18549638
[TBL] [Abstract][Full Text] [Related]
11. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
MacDonald KP; Rowe V; Filippich C; Thomas R; Clouston AD; Welply JK; Hart DN; Ferrara JL; Hill GR
Blood; 2003 Mar; 101(5):2033-42. PubMed ID: 12393418
[TBL] [Abstract][Full Text] [Related]
12. Transplant Outcomes in Beta-Thalassemia Major Patients Receiving Combined Granulocyte Colony-Stimulating Factor-Primed Bone Marrow and Cord Blood Graft Compared to Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Alone.
Wen J; Haque Q; Pei F; Chen L; Ruan Y; Liu X; He Y; Feng X; Li C; Wu X
Acta Haematol; 2018; 140(1):20-29. PubMed ID: 30071526
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow graft-versus-host disease: evaluation of its clinical impact on disrupted hematopoiesis after allogeneic hematopoietic stem cell transplantation.
Shono Y; Shiratori S; Kosugi-Kanaya M; Ueha S; Sugita J; Shigematsu A; Kondo T; Hashimoto D; Fujimoto K; Endo T; Nishio M; Hashino S; Matsuno Y; Matsushima K; Tanaka J; Imamura M; Teshima T
Biol Blood Marrow Transplant; 2014 Apr; 20(4):495-500. PubMed ID: 24374213
[TBL] [Abstract][Full Text] [Related]
14. Pilot study of allogeneic G-CSF-stimulated bone marrow transplantation: harvest, engraftment, and graft-versus-host disease.
Ostronoff M; Ostronoff F; Souto Maior P; Matias C; Calixto R; Sucupira A; Domingues M; Florencio R; Tagliari C
Biol Blood Marrow Transplant; 2006 Jul; 12(7):729-33. PubMed ID: 16785062
[TBL] [Abstract][Full Text] [Related]
15. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
[TBL] [Abstract][Full Text] [Related]
16. Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.
Ji S; Chen H; Wang H; Ma J; Pan S; Xue M; Zhu L; Liu J; Xiao M; Zhou L
Chin Med J (Engl); 2001 Feb; 114(2):191-5. PubMed ID: 11780205
[TBL] [Abstract][Full Text] [Related]
17. Expression profiles of adhesion molecules on naïve T cells in bone marrow grafts of healthy donors treated with granulocyte colony-stimulating factor.
Chang YJ; Zhao XY; Huo MR; Huang XJ
Transpl Immunol; 2009 Sep; 21(4):228-33. PubMed ID: 19467326
[TBL] [Abstract][Full Text] [Related]
18. Effect of the in vivo application of granulocyte colony-stimulating factor on NK cells in bone marrow and peripheral blood.
Yu XX; Han TT; Xu LL; Chang YJ; Huang XJ; Zhao XY
J Cell Mol Med; 2018 Jun; 22(6):3025-3034. PubMed ID: 29575692
[TBL] [Abstract][Full Text] [Related]
19. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.
Vendramin A; Gimondi S; Bermema A; Longoni P; Rizzitano S; Corradini P; Carniti C
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2049-55. PubMed ID: 25246295
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.
Pan L; Delmonte J; Jalonen CK; Ferrara JL
Blood; 1995 Dec; 86(12):4422-9. PubMed ID: 8541530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]